After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The post Down 15% and with a P/E below 9!

DeepSeek has rattled the AI industry. Here’s a quick look at other Chinese AI models ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

"GSK stays optimistic on vaccines amidst US and China woes " was originally created and published by Pharmaceutical ...

UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold ...

(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo ...

In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK's core operating profit rose 11% year on year in 2024 to ... ongoing cost of running powerful AI models and the Chinese ...

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...